X-FAB Silicon Foundries (XFAB) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
26 Jun, 2026Executive summary
Q3 2024 revenue was $206.4 million, down 12% year-over-year but up 1% sequentially, within guidance.
Automotive segment grew 8% year-over-year, driven by strong growth in China, while industrial and medical segments declined 41% and 29% respectively.
Bookings totaled $217.1 million, up 4% year-over-year, with a book-to-bill ratio of 1.05 and backlog at $481.4 million.
Operational incident in Malaysia caused a three-day slowdown, shifting $15–20 million revenue from Q4 to Q1 2025.
EBIT for Q3 was $25.0 million (12.1% margin), and EBITDA was $50.3 million (24.4% margin).
Financial highlights
Gross profit for Q3 was $51.2 million, gross margin 24.8%, down from 29.8% a year ago but up 14% sequentially.
Net income for Q3 was $25.95 million, EPS $0.20, down from $0.32 in Q3 2023.
CapEx in Q3 was $149.8 million, mainly for Malaysia/Sarawak expansion; full-year CapEx guidance at $550 million.
Cash and cash equivalents at quarter-end were $315.9 million.
Net debt stood at $51.3 million as of September 30, 2024.
Outlook and guidance
Q4 2024 revenue expected between $195–205 million; EBITDA margin guidance at 22–25%.
Full-year 2024 revenue guidance revised to $822–832 million (from $860–880 million); EBITDA margin guidance now 23.4–24.0%.
CapEx for 2024 projected at $550 million; significant drop in CapEx expected after Q1 2025.
SiC revenue target for 2026 ($300–350 million) no longer achievable due to capacity and product mix changes.
Latest events from X-FAB Silicon Foundries
- Q4 2024 revenue and profit fell amid auto destocking; CapEx to drop and recovery expected in 2025.XFAB
Q4 202426 Jun 2026 - Q3 2025 revenue up 12% YoY to $229M, led by industrial and medical growth; order intake fell.XFAB
Q3 202526 Jun 2026 - Q1 2026 revenue was $195.6M, with strong growth in industrial, medical, and microsystems.XFAB
Q1 202610 May 2026 - Q4 revenue up 18% YoY to $222.3M; industrial and medical growth offset automotive softness.XFAB
Q4 20259 Feb 2026 - Q2 revenue fell 9% year-on-year to $205.1M; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 20242 Feb 2026 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 202411 Jan 2026 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
CMD 202531 Dec 2025 - Q1 revenue up 8% sequentially, EBITDA margin 24%, guidance and expansion plans reaffirmed.XFAB
Q1 202523 Dec 2025 - Q2 revenue up to 8% year-over-year, guidance raised, and capacity expansion completed.XFAB
Q2 202516 Nov 2025